Alcohol Changed Selected THC Pharmacokinetic Measures Without Uniform Metabolite Effects

Alcohol did not shift every cannabinoid measurement in the same direction in a controlled study of heavy cannabis users. Selected THC pharmacokinetic changes occurred while metabolite comparisons remained nonsignificant.

The observed alcohol levels differed from targets

Nineteen heavy cannabis users received three alcohol conditions, then smoked a THC cigarette during the dosing period. The reported mean steady alcohol concentrations were lower than the planned targets. An account of the experiment should use achieved exposure rather than present the targets as observed values.

Some THC results changed

The higher alcohol condition was associated with a modestly longer apparent THC elimination half-life and a lower concentration at one reported post-smoking time. The authors proposed distribution between compartments as one possible explanation.

Metabolite findings were not equivalent positives

The abstract reports no significant ethanol effect on the measured pharmacokinetics of 11-hydroxy-THC or the carboxy metabolite. A visually lower or numerically different concentration is not automatically a statistically established effect.

The study used serial blood sampling; its measurements should retain the exact analytical matrix when quantitative values are applied elsewhere. An apparent half-life is not the duration of intoxication and does not determine a person's driving clearance. Nor do these exposure findings establish behavioral cross-tolerance to alcohol. The useful result is an analyte- and time-specific interaction under a defined research regimen.

Related: interpreting cannabis tolerance claims.

Research cited

Toennes SW; Schneider K; Kauert GF; Wunder C; Moeller MR; Theunissen EL; Ramaekers JG. Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. Analytical and bioanalytical chemistry (2011). doi:10.1007/s00216-010-4449-2. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us